IBDEI0PG ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11439,0)
 ;;=J3370^^45^549^16^^^^1
 ;;^UTILITY(U,$J,358.3,11439,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11439,1,2,0)
 ;;=2^Vancomycin HCL 500 MG
 ;;^UTILITY(U,$J,358.3,11439,1,3,0)
 ;;=3^J3370
 ;;^UTILITY(U,$J,358.3,11440,0)
 ;;=J0882^^45^549^3^^^^1
 ;;^UTILITY(U,$J,358.3,11440,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11440,1,2,0)
 ;;=2^Darbepoetin Alfa,ESRD Use,1 MCG
 ;;^UTILITY(U,$J,358.3,11440,1,3,0)
 ;;=3^J0882
 ;;^UTILITY(U,$J,358.3,11441,0)
 ;;=J0881^^45^549^4^^^^1
 ;;^UTILITY(U,$J,358.3,11441,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11441,1,2,0)
 ;;=2^Darbepoetin Alfa,Non-ESRD,1 MCG
 ;;^UTILITY(U,$J,358.3,11441,1,3,0)
 ;;=3^J0881
 ;;^UTILITY(U,$J,358.3,11442,0)
 ;;=J0885^^45^549^7^^^^1
 ;;^UTILITY(U,$J,358.3,11442,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11442,1,2,0)
 ;;=2^Epoetin Alfa,Non-ESRD,1000 Units
 ;;^UTILITY(U,$J,358.3,11442,1,3,0)
 ;;=3^J0885
 ;;^UTILITY(U,$J,358.3,11443,0)
 ;;=J1642^^45^549^11^^^^1
 ;;^UTILITY(U,$J,358.3,11443,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11443,1,2,0)
 ;;=2^Heparin Sodium per 10 Units
 ;;^UTILITY(U,$J,358.3,11443,1,3,0)
 ;;=3^J1642
 ;;^UTILITY(U,$J,358.3,11444,0)
 ;;=Q4081^^45^549^6^^^^1
 ;;^UTILITY(U,$J,358.3,11444,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11444,1,2,0)
 ;;=2^Epoetin Alfa,ESRD Use,100 Units
 ;;^UTILITY(U,$J,358.3,11444,1,3,0)
 ;;=3^Q4081
 ;;^UTILITY(U,$J,358.3,11445,0)
 ;;=92950^^45^550^5^^^^1
 ;;^UTILITY(U,$J,358.3,11445,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11445,1,2,0)
 ;;=2^Heart/Lung Resuscitation CPR
 ;;^UTILITY(U,$J,358.3,11445,1,3,0)
 ;;=3^92950
 ;;^UTILITY(U,$J,358.3,11446,0)
 ;;=93224^^45^550^3^^^^1
 ;;^UTILITY(U,$J,358.3,11446,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11446,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Intrp & Rpt
 ;;^UTILITY(U,$J,358.3,11446,1,3,0)
 ;;=3^93224
 ;;^UTILITY(U,$J,358.3,11447,0)
 ;;=93225^^45^550^4^^^^1
 ;;^UTILITY(U,$J,358.3,11447,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11447,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Recording Only
 ;;^UTILITY(U,$J,358.3,11447,1,3,0)
 ;;=3^93225
 ;;^UTILITY(U,$J,358.3,11448,0)
 ;;=93226^^45^550^1^^^^1
 ;;^UTILITY(U,$J,358.3,11448,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11448,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Analysis & Rpt
 ;;^UTILITY(U,$J,358.3,11448,1,3,0)
 ;;=3^93226
 ;;^UTILITY(U,$J,358.3,11449,0)
 ;;=93227^^45^550^2^^^^1
 ;;^UTILITY(U,$J,358.3,11449,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11449,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Intrp
 ;;^UTILITY(U,$J,358.3,11449,1,3,0)
 ;;=3^93227
 ;;^UTILITY(U,$J,358.3,11450,0)
 ;;=36245^^45^551^1^^^^1
 ;;^UTILITY(U,$J,358.3,11450,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11450,1,2,0)
 ;;=2^Ins Cath Abd/L-Ext Art,1st
 ;;^UTILITY(U,$J,358.3,11450,1,3,0)
 ;;=3^36245
 ;;^UTILITY(U,$J,358.3,11451,0)
 ;;=96523^^45^551^2^^^^1
 ;;^UTILITY(U,$J,358.3,11451,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11451,1,2,0)
 ;;=2^Irrig Drug Delivery Device
 ;;^UTILITY(U,$J,358.3,11451,1,3,0)
 ;;=3^96523
 ;;^UTILITY(U,$J,358.3,11452,0)
 ;;=99366^^45^552^1^^^^1
 ;;^UTILITY(U,$J,358.3,11452,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11452,1,2,0)
 ;;=2^Med Team Conf FTF > 29 min
 ;;^UTILITY(U,$J,358.3,11452,1,3,0)
 ;;=3^99366
 ;;^UTILITY(U,$J,358.3,11453,0)
 ;;=99367^^45^552^2^^^^1
 ;;^UTILITY(U,$J,358.3,11453,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11453,1,2,0)
 ;;=2^Med Team Conf w/o FTF;Physician
